The Chemours Co.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US1638511089
USD
12.54
-0.42 (-3.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The Chemours Co. stock-summary
stock-summary
The Chemours Co.
Specialty Chemicals
The Chemours Co is a provider of performance chemicals. The Company provides a range of industrial and specialty chemicals products for markets, including plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining. Its segments include Fluoroproducts segment, Chemical Solutions segment and Titanium Technologies segment. Fluoroproducts segment is a provider of fluorine-based, advanced materials solutions, such as refrigerants and industrial resins and derivatives. Chemical Solutions segment is comprised of a portfolio of industrial chemical businesses, primarily operating in the Americas. Titanium Technologies segment is a manufacturer of TiO2 pigment. The Company serves various industries, such as electronics, communications, automotive, wire and cable, energy, oil and gas, and aerospace.
Company Coordinates stock-summary
Company Details
1007 Market St , WILMINGTON DE : 19898-1100
stock-summary
Tel: 1 302 7731000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 84 Schemes (60.53%)

Foreign Institutions

Held by 159 Foreign Institutions (16.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Richard Brown
Independent Chairman of the Board
Mr. Mark Vergnano
President, Chief Executive Officer, Director
Mr. Curtis Anastasio
Independent Director
Mr. Bradley Bell
Independent Director
Ms. Mary Cranston
Independent Director
Dr. Curtis Crawford
Independent Director
Ms. Dawn Farrell
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,615 Million
(Quarterly Results - Jun 2025)
Net Profit:
-380 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 2,884 Million (Small Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

130.55%

stock-summary
Debt Equity

15.48

stock-summary
Return on Equity

13.50%

stock-summary
Price to Book

12.17